IL308068A - A method for dose titration of psychedelics - Google Patents

A method for dose titration of psychedelics

Info

Publication number
IL308068A
IL308068A IL308068A IL30806823A IL308068A IL 308068 A IL308068 A IL 308068A IL 308068 A IL308068 A IL 308068A IL 30806823 A IL30806823 A IL 30806823A IL 308068 A IL308068 A IL 308068A
Authority
IL
Israel
Prior art keywords
psychedelics
titrating
dose
titrating dose
Prior art date
Application number
IL308068A
Other languages
English (en)
Hebrew (he)
Inventor
Robert Barrow
Daniel R Karlin
Original Assignee
Mind Medicine Inc
Robert Barrow
Daniel R Karlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mind Medicine Inc, Robert Barrow, Daniel R Karlin filed Critical Mind Medicine Inc
Publication of IL308068A publication Critical patent/IL308068A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measurement Of Radiation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Dental Preparations (AREA)
IL308068A 2021-05-03 2022-05-01 A method for dose titration of psychedelics IL308068A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163183579P 2021-05-03 2021-05-03
PCT/US2022/027179 WO2022235529A1 (en) 2021-05-03 2022-05-01 Method of titrating dose of psychedelics

Publications (1)

Publication Number Publication Date
IL308068A true IL308068A (en) 2023-12-01

Family

ID=83932279

Family Applications (1)

Application Number Title Priority Date Filing Date
IL308068A IL308068A (en) 2021-05-03 2022-05-01 A method for dose titration of psychedelics

Country Status (7)

Country Link
EP (1) EP4333979A1 (ja)
JP (1) JP2024517194A (ja)
AU (1) AU2022268891A1 (ja)
CA (1) CA3216939A1 (ja)
IL (1) IL308068A (ja)
TW (1) TW202245767A (ja)
WO (1) WO2022235529A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2023014620A (es) 2021-06-09 2024-01-30 Atai Therapeutics Inc Nuevos profarmacos y conjugados de dimetiltriptamina.
JP2024531437A (ja) 2021-08-20 2024-08-29 ファーマラ バイオテック インコーポレイテッド （ｒ）－３，４－メチレンジオキシメタンフェタミン及び（ｓ）－３，４－メチレンジオキシメタンフェタミン又は（ｒ）ｎ－メチル－１，３－ベンゾジオキソリルブタンアミン及び（ｓ）ｎ－メチル－１，３－ベンゾジオキソリルブタンアミンの非ラセミ混合物を含む組成物、並びにその使用
AU2022425541A1 (en) 2021-12-30 2024-06-06 Atai Therapeutics, Inc. Dimethyltryptamine analogues as nitric oxide delivery drugs
US20230202978A1 (en) 2022-03-04 2023-06-29 Reset Pharmaceuticals, Inc. Co-crystal or salt

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11723894B2 (en) * 2017-10-26 2023-08-15 Terran Biosciences, Inc. Combination product for the treatment of neurological and/or psychiatric disorders
CA3146050A1 (en) * 2019-07-04 2021-01-07 Sw Holdings, Inc. Metered dosing compositions and methods of use of psychedelic compounds

Also Published As

Publication number Publication date
WO2022235529A1 (en) 2022-11-10
AU2022268891A1 (en) 2023-11-09
JP2024517194A (ja) 2024-04-19
EP4333979A1 (en) 2024-03-13
CA3216939A1 (en) 2022-11-10
TW202245767A (zh) 2022-12-01

Similar Documents

Publication Publication Date Title
IL308068A (en) A method for dose titration of psychedelics
IL292754A (en) method of synthesis
GB2584946B (en) Method of selecting ions
GB2590601B (en) Method of mass spectrometry
GB201804594D0 (en) Bonegraft substituteand method of manufacture
IL287210A (en) Preparations for the treatment of tumors
GB201802839D0 (en) Method of manufacture
SG10202003054XA (en) Manufacturing method of chips
EP3980796C0 (en) CYCLIC COULOMETRY METHOD
IL289811A (en) A method for treating cancer
SG11202113371VA (en) Method of synthesizing chemical compounds
GB2553390B (en) Method of manufacture
GB201900971D0 (en) Insole apparatus and method of manufacture thereof
IL287250A (en) Method of treatment
IL280064A (en) A method for preparing a substrate for creating an aerosol
GB202015840D0 (en) Method of forming an electrode
SG11202105877YA (en) Method of treatment
GB201911056D0 (en) Treatment of ADD/ADHD
GB2561372B (en) Method of producing ions
GB2602912B (en) Method of packaging
GB201704816D0 (en) Method of manufacture
GB201905379D0 (en) Method of epoxidation
ZA201903823B (en) Method of encapsulation
GB201906748D0 (en) Method of formulation
GB202106258D0 (en) Method of formulation